✦ LIBER ✦

Increasing apoA-I production as a target for CHD risk reduction

✍ Scribed by Stefan P.J. Dullens; Jogchum Plat; Ronald P. Mensink

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The rationale for using apoA-I as a clin

✍ P. J. BARTER; K.-A. RYE 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 295 KB

Sleep-Time Blood Pressure as a Therapeut

✍ Hermida, Ramón C.; Ayala, Diana E.; Mojón, Artemio; Fernández, José R. 📂 Article 📅 2012 🏛 Nature Publishing Group 🌐 English ⚖ 265 KB

Sleep-Time Blood Pressure: Prognostic Va

✍ Hermida, Ramón C.; Ayala, Diana E.; Fernández, José R.; Mojón, Artemio 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 670 KB

G24 - Proteinuria as a marker for patien

✍ R M Guthrie; J Lott; B A Guthrie; S Cattaneo; V Witmer 📂 Article 📅 1995 🏛 Nature Publishing Group 🌐 English ⚖ 176 KB

OPTIMAL CONDITIONS TO OBTAIN HIGH PURITY

✍ ALANIS, JOSE; NAVARRETE, MANUEL 📂 Article 📅 2000 🏛 Taylor and Francis Group 🌐 English ⚖ 192 KB

Lipoprotein(a) as a Potential Causal Gen

✍ Sotirios Tsimikas; Jennifer L. Hall 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 456 KB